AMBER THERAPEUTICS HOLDINGS LIMITED
🏛️Establishedactive
13089338 · ltd · incorporated 2020-12-18
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Dec 2024
Net worth
—
book net assets
Opportunity
76/100
Strong
What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
PursueStrong opportunity: active trading company with strong profile and bankable structure.
Opportunity 76/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
8 officers (6 active, 8 linked, 8 with DOB)
90
Ownership & PSC
1 active PSC(s) of 3 total, 3 with control declared
90
Director network
2 connected companies via shared directors
51
Filing history
62 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
76/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
65
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Key financials
2 years extracted from filed iXBRL accountsCash
—
Net Worth
—
Current Assets
—
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Average employees | 0 | 600 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (34 events)Click to expand
- 2025-12-23📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2025-12-23📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2025-12-18📄replacement-filing-of-director-appointment-with-nameofficers · RP01AP01
- 2025-09-05📄accounts-with-accounts-type-groupaccounts · AA
- 2025-09-04📄capital-allotment-sharescapital · SH01
- 2025-09-04📄capital-allotment-sharescapital · SH01
- 2025-06-17📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-06-16📄second-filing-capital-allotment-sharescapital · RP04SH01
- 2025-06-16📄second-filing-capital-allotment-sharescapital · RP04SH01
- 2025-06-16📄capital-allotment-sharescapital · SH01
- 2025-04-16📄capital-allotment-sharescapital · SH01
- 2025-04-16📄capital-allotment-sharescapital · SH01
- 2025-04-15➕AMERSON, David Rogers appointeddirector
- 2025-04-15📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-02-04📄capital-allotment-sharescapital · SH01
- 2025-02-03📄second-filing-capital-allotment-sharescapital · RP04SH01
- 2025-01-29📄capital-allotment-sharescapital · SH01
- 2024-11-12📄capital-allotment-sharescapital · SH01
- 2024-09-18📄accounts-with-accounts-type-groupaccounts · AA
- 2024-08-24📄capital-allotment-sharescapital · SH01
- 2024-07-11✏️certificate-change-of-name-companychange-of-name · CERTNM
- 2024-07-11✏️change-of-name-noticechange-of-name · CONNOT
- 2024-06-06📄capital-allotment-sharescapital · SH01
- 2024-05-31📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2024-05-23➕BUTLER, Caroline appointeddirector
- 2024-05-23➕CHU, Yen-Min Kevin appointeddirector
- 2024-05-23➕LE, Tiffany appointeddirector
- 2024-05-23➖DENISON, Tim resigneddirector
- 2024-04-30➖GLENN, Jonathan Martin resigneddirector
- 2023-12-01➕GLENN, Jonathan Martin appointeddirector
- 2021-06-18➕CHAMAS, Liliane, Doctor appointeddirector
- 2021-06-18➕DENISON, Tim appointeddirector
- 2020-12-18🏢Company incorporatedAs AMBER THERAPEUTICS HOLDINGS LIMITED
- 2020-12-18➕CRAWLEY, Aidan Harold Winston appointeddirector
Owner dependency
48/100
Moderate — manageable with handoverSome founder dependency, but not acute. A structured handover period should cover most risk.
FACTORS
- -6 active directors: Broader management team in place — suggests transferable governance.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
Succession & seller-readiness
50/100
Moderate signalSome succession indicators present. Worth watching; approach if sector/strategy fits.
SIGNALS
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Group structure
Oxford Science Enterprises Holdings Ii Limited holds 25-50% — a significant corporate investor but not a controlling parent.
🏛️significant stake
Oxford Science Enterprises Holdings Ii Limited
Corporate parent · holds 25-50% shares
⬇
AMBER THERAPEUTICS HOLDINGS LIMITED
This company · 13089338
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Oxford Science Enterprises Holdings Ii Limited Corporate entity | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 28/05/2025 |
2 historic (ceased) PSCs
- Oxford Science Enterprises Plcceased 28/05/2025· 25-50% shares · 25-50% voting
- Aidan Harold Winston Crawleyceased 18/06/2021· 75-100% shares · 75-100% voting · board control
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
🔒Co-director network graph
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · OX postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A MURFIN CONSULTING LTD→ 15881767 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALEXANDER LOWEN LIMITED→ 17076650 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALLEN VENTURES SERVICES UK LTD→ 12589139 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ALLIANCE MANAGEMENT & CONSULTANCY LTD→ 12962869 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ALTIUS COACHING AND CONSULTING LTD→ 09608702 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ALVEOGENE LIMITED→ 14342459 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AMAZON LTD→ 10804351 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AMB14 LIMITED→ 08920835 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| AMBER FINANCIAL MANAGEMENT LTD→ 06637748 · est 2008 · no financials extracted | — | — | — | — | 17y | — | — |
| AMBERBROOKE ADVISERS LTD→ 13305252 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| AMBIANCE DEVELOPMENTS LTD→ 08852972 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| AMBION CONSULTANTS LIMITED→ 03027094 · est 1995 · no financials extracted | — | — | — | — | 31y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2020-12-18
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology
Registered office
Unit 1 Tech Foundry 2
Curie Avenue
Didcot
OX11 0QQ
England
Filing status
Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2026-12-31
Last: 2025-12-17
Officers (6 active · 2 resigned)
AMERSON, David Rogers→
Activedirector · ~64y · appointed 2025-04-15
View their other companies + combined net worth →
BUTLER, Caroline→
Activedirector · ~46y · appointed 2024-05-23
View their other companies + combined net worth →
CHAMAS, Liliane, Doctor→
Activedirector · ~40y · appointed 2021-06-18
View their other companies + combined net worth →
CHU, Yen-Min Kevin→
Activedirector · ~37y · appointed 2024-05-23
View their other companies + combined net worth →
CRAWLEY, Aidan Harold Winston→
Activedirector · ~43y · appointed 2020-12-18
View their other companies + combined net worth →
Active
DENISON, Tim→
Resigneddirector · ~56y · appointed 2021-06-18 · resigned 2024-05-23
GLENN, Jonathan Martin→
Resigneddirector · ~58y · appointed 2023-12-01 · resigned 2024-04-30
Click a director name to see their full track record across all companies.
Recent filings (62 total)
confirmation-statement-with-updates
confirmation-statement · CS01
2025-12-24
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC02
2025-12-23
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-12-23
replacement-filing-of-director-appointment-with-name
officers · RP01AP01
2025-12-18
accounts-with-accounts-type-group
accounts · AA
2025-09-05
capital-allotment-shares
capital · SH01
2025-09-04
capital-allotment-shares
capital · SH01
2025-09-04
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-06-17
second-filing-capital-allotment-shares
capital · RP04SH01
2025-06-16
second-filing-capital-allotment-shares
capital · RP04SH01
2025-06-16
capital-allotment-shares
capital · SH01
2025-06-16
capital-allotment-shares
capital · SH01
2025-04-16
capital-allotment-shares
capital · SH01
2025-04-16
appoint-person-director-company-with-name-date
officers · AP01
2025-04-15
capital-allotment-shares
capital · SH01
2025-02-04